Z-1797-2018 Class II Terminated

Recalled by Diagnostic Hybrids, Inc. — Athens, OH

FDA device recall Z-1797-2018 was initiated by Diagnostic Hybrids, Inc. on Jul 14, 2016 and is designated Class II. Reason for recall: There is a possibility of low volume and/or leaking standard bottles. The recall status is terminated (terminated Aug 28, 2020). Affected quantity: 1004.

Recall details

Product Type
Devices
Report Date
May 16, 2018
Initiation Date
Jul 14, 2016
Termination Date
Aug 28, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1004

Product description

MicroVue BAP EIA, Model 8012, provides a quantitative measure of bone-specific alkaline phosphatase (BAP) activity in serum.

Reason for recall

There is a possibility of low volume and/or leaking standard bottles.

Distribution pattern

The products were distributed to the following US states: CA, CT, GA, IL, KY, MA, MD, MO, PA, TX, WA, and WI. The products were distributed to the following foreign countries: Australia, Brazil, Canada, China, Costa Rica, India, Japan, Mexico, The Philippines, Russia, South Korea, South Africa, Switzerland, and Uruguay.

Code information

Lot 067850

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1797-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1797-2018. Report a data issue: hello@regdatalab.com.